Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Psychological and physical predictors of illness intrusiveness in patients with multiple sclerosis.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
The right-to-die campaigner who won a key legal ruling.
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Regulatory dendritic cell therapy: From rodents to clinical application.
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Pages
« first
‹ previous
…
501
502
503
504
505
506
507
508
509
…
next ›
last »